PF-05161704 or placebo

DRUG2 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2

Phase 1

A Single Dose Study Of PF-05161704 In Healthy Volunteers

CompletedNCT01183715

PfizerDiabetes Mellitus, Type 2

Start: 2010-07-31End: 2010-09-30Updated: 2019-07-23

A Multiple Dose Study Of PF-05161704 In Healthy Volunteers

TerminatedNCT01202266

PfizerDiabetes Mellitus, Type 2

Start: 2010-08-31End: 2010-12-31Updated: 2011-03-11